Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Oral apixaban
DRUG
2 trials
Sponsors
University of Colorado, Denver
, Shanghai Zhongshan Hospital
Conditions
Evaluate the Safety and Efficacy of Apixaban
Gynecologic Cancer
Venous Thromboembolism
Phase 2
Oral Apixaban (Eliquis) Versus Enoxaparin (Lovenox) for Thromboprophylaxis in Women With Suspected Pelvic Malignancy
Completed
NCT02366871
University of Colorado, Denver
Gynecologic Cancer, Venous Thromboembolism
Start: 2015-04-28
End: 2019-06-30
Updated: 2020-03-31
Unknown Phase
A Multi-center Study of Apixaban(APPROACH)
NCT04550637
Shanghai Zhongshan Hospital
Evaluate the Safety and Efficacy of Apixaban
Start: 2022-07-04
End: 2024-12-31
Target: 200
Updated: 2022-10-18
Related Papers
Safety and Efficacy of Apixaban vs Enoxaparin for Preventing Postoperative Venous Thromboembolism in Women Undergoing Surgery for Gynecologic Malignant Neoplasm
JAMA Network Open
2020-06-26
120 citations
Apixaban for Primary Prevention of Venous Thromboembolism in Patients With Multiple Myeloma Receiving Immunomodulatory Therapy
Frontiers in Oncology
2019-02-26
33 citations